1,494 results on '"Guckenberger M"'
Search Results
2. European Society of Radiotherapy and Oncology (ESTRO) strategy 2024–2026: Growth and diversification in a rapidly changing world
3. Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial
4. Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline
5. ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases
6. SMILE: Stereotaktische MRT-geführte Radiotherapie von lokal begrenzten Prostatakarzinomen: Eine multizentrische Phase-II-Studie
7. Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14
8. Konzepte beim oligometastasierten Lungenkarzinom
9. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)
10. The impact of clinical audits on patient radiation exposure for device procedures
11. Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung – The Knockout Punch
12. Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials
13. Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial
14. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)
15. Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)
16. PEACE V–Salvage Treatment of oligorecurrent nodal prostate cancer metastases (STORM): 24-months toxicity results of a randomized phase II trial
17. Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose
18. High-dose re-irradiation of intracranial lesions – Efficacy and safety including dosimetric analysis based on accumulated EQD2Gy dose calculation
19. The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas
20. ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
21. ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
22. ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases
23. P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel
24. Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline
25. MA11.09 SAKK 16/18: Neoadjuvant Chemotherapy, Durvalumab and Immune-Modulatory RT in Stage III(N2) NSCLC. Surgical Interim Analysis
26. What MRI Sequences are Necessary for Automated Neural Network-Based Metastasis Segmentation ― An Ablation Study
27. Post-Operative Stereotactic Radiotherapy for Resected Brain Metastases: Results of the Multicenter Analysis (AURORA) of the German Working Group "Stereotactic Radiotherapy"
28. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
29. Grundlagen der Oligometastasierung und Stellenwert der Lokaltherapie
30. Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study
31. Response to “Are roots really not worth considering?”
32. Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy
33. Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries
34. PD-0668 Phantom measurements of apparent diffusion coefficient on a 0.35T MR-Linac
35. PO-1606 Metastatic tumor burden in cancer patients: implications for the oligometastatic spectrum theory
36. SP-0845 Does a department need to be active in research or trials in order to offer the best patient care?
37. PO-2174 Implementation of new safety and security measures for a brachytherapy treatment room
38. PO-1607 Same-day MRI-LINAC guided single fraction radiosurgery for painful non-spine bone metastases
39. MO-0640 Structural cardiac changes in cardiac MRI after SBRT for targets in close proximity to the heart
40. OC-0435 Multi-institutional nomogram for PSMA-PET based salvage radiotherapy in recurrent prostate cancer
41. OC-0764 The rate and spatial location of local recurrences: Results from the EORTC 22922/10925
42. OC-0271 SBRT for spine metastases: A systematic review for preparation of an ESTRO practice guideline
43. PD-0485 Open-face vs. closed masks: a randomized trial assessing patient comfort in cranial radiotherapy
44. OC-0269 Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare cohort
45. OC-0270 Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations
46. PO-1572 Recognition and treatment recommendations of oligometastasis in multidisciplinary tumor boards
47. MO-0561 Defining Patient Empowerment from a radiation oncology perspective: An Expert and patient consensus
48. SP-0999 ASTRO-ESTRO guideline on oligometastatic NSCLC
49. PD-0808 Mortality during or shortly after Curative-Intent Radio-(Chemo-)Therapy
50. OC-0611 Lungtech EORTC 22113-08113 prospective multicenter trial: SBRT for central lung tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.